| 1 | Other: Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsq | [8] Alemtuzumab Alemtuzumab, Cladribine, Hyaluronidase, Natalizumab, Ocrelizumab, Ofatumumab, Rituximab, Ublituximab (Ublituximab) | [10] Cladribine
Cladribine
,
Alemtuzumab
,
Rituximab
,
Hyaluronidase
,
Hyaluronidase
,
Ocrelizumab
,
Hyaluronidase
,
Natalizumab
,
Ofatumumab
,
Ublituximab
(Ublituximab) 💬
| [3] ITGA4 ITGA4, MS4A1, RRM1 💬
| [21] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Focal adhesion, Glutathione metabolism, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 💬
|